1. Home
  2. UVV vs PGEN Comparison

UVV vs PGEN Comparison

Compare UVV & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Corporation

UVV

Universal Corporation

HOLD

Current Price

$54.38

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.30

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVV
PGEN
Founded
1886
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
UVV
PGEN
Price
$54.38
$4.30
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$8.33
AVG Volume (30 Days)
131.4K
2.9M
Earning Date
05-28-2026
05-13-2026
Dividend Yield
6.25%
N/A
EPS Growth
N/A
N/A
EPS
3.02
N/A
Revenue
$2,922,924,000.00
$230,981,000.00
Revenue This Year
$0.67
$1,115.92
Revenue Next Year
$0.10
$81.04
P/E Ratio
$18.06
N/A
Revenue Growth
7.40
N/A
52 Week Low
$49.96
$1.28
52 Week High
$67.33
$5.47

Technical Indicators

Market Signals
Indicator
UVV
PGEN
Relative Strength Index (RSI) 56.20 54.13
Support Level $53.85 $3.96
Resistance Level $56.52 $4.40
Average True Range (ATR) 0.83 0.24
MACD 0.04 -0.01
Stochastic Oscillator 58.81 37.50

Price Performance

Historical Comparison
UVV
PGEN

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: